Aqua Medical

Aqua Medical today announced the presentation of 12-month follow-up data for its proprietary radiofrequency vapor ablation (RFVA) platform. Pleasanton, California-based Aqua Medical designed its Proximal Intestinal Mucosal Ablation (PIMA) procedure to use its proprietary RFVA system. PIMA, a minimally invasive outpatient endoscopic procedure, … [Read more...] about Aqua Medical shares data backing ablation procedure for treating diabetes

Aqua Medical has received an investigational device exemption (IDE) from the FDA for its ablation device intended to treat diabetes, the company told MassDevice ahead of an official announcement later today. The IDE gives the device developer the green light to conduct a pilot clinical trial of its Proximal Intestinal Mucosal Ablation (PIMA) … [Read more...] about Aqua Medical wins FDA IDE to launch trial for ablation procedure that treats diabetes